Wednesday, May 20, 2026
RSS

Defense

Red Cat's Acquisition of Quaze Technologies: A Game Changer for Autonomous Systems

Red Cat Holdings' acquisition of Quaze Technologies boosts its capabilities in autonomous systems with innovative wireless power technology.

By Sarah Chen • May 20, 2026
Tech

Expedia Group's Acquisition of CarTrawler: A Bold Step Towards B2B Travel Expansion

Expedia's acquisition of CarTrawler marks a significant move to enhance B2B travel services, diversifying revenue streams.

James McAllister • May 20
Tech

Envirotech Vehicles and AZIO AI: A $750M Merger in Electric Vehicle Innovation

Envirotech Vehicles and AZIO AI have signed a $750M merger agreement, signaling a potential shift in the electric vehicle market.

Catherine Walsh • May 20
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Pharmaceutical

Humacyte's VA Contract: A Milestone for Symvess Surgical Implants

Humacyte secures a vital contract with the VA for Symvess, boosting access to 170 hospitals and highlighting its potenti…

Tyler Brooks • May 20, 2026
Tech

Cycurion's Strategic Move: Integrating Halo Privacy for Enhanced Cybersecurity

Cycurion's acquisition of Halo Privacy aims to bolster its position in the cybersecurity market with advanced secure com…

Diana Kowalski • May 20, 2026
Tech

Expedia Group's B2B Expansion: The Strategic Acquisition of CarTrawler

Expedia Group's acquisition of CarTrawler bolsters its B2B travel platform, enhancing competitiveness and revenue potent…

Marcus Rivera • May 20, 2026
Defense

Red Cat's Acquisition of Quaze Technologies: Pioneering Wireless Power in Defense Drones

Red Cat's acquisition of Quaze Technologies could revolutionize wireless power in defense drones, reshaping operational …

Sarah Chen • May 20, 2026
Pharmaceutical

Eli Lilly's Strategic Acquisition of Engage Bio: A Game Changer in Gene Therapy

Eli Lilly's acquisition of Engage Bio for up to $202 million positions it as a key player in non-viral gene delivery.

James McAllister • May 20, 2026